What is the Fib‑4 score for a 54‑year‑old patient with ALT 38 U/L, AST 37 U/L, and platelet count 150 000/µL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

FIB-4 Score Calculation

For this 54-year-old patient with ALT 38 U/L, AST 37 U/L, and platelet count 150,000/µL, the FIB-4 score is 1.03, which falls in the low-risk category and effectively rules out advanced liver fibrosis.

Calculation Method

The FIB-4 formula is: [Age (years) × AST (U/L)] / [Platelet count (10⁹/L) × √ALT (U/L)] 1

For this patient:

  • FIB-4 = (54 × 37) / (150 × √38)
  • FIB-4 = 1,998 / (150 × 6.16)
  • FIB-4 = 1,998 / 924
  • FIB-4 = 1.03

Clinical Interpretation

Risk Stratification Based on Current Guidelines

This score of 1.03 indicates low risk for advanced fibrosis 1, 2:

  • **FIB-4 <1.3**: Rules out advanced fibrosis with high negative predictive value (>90%) and sensitivity of 80-89% 1, 2
  • FIB-4 1.3-2.67 (or 1.3-3.25): Indeterminate zone requiring additional testing
  • FIB-4 >2.67 (or >3.25): High risk for advanced fibrosis with specificity of 94% 1, 2

Clinical Action Based on This Score

Since the FIB-4 is 1.03 (<1.3), this patient:

  • Does not require immediate referral for additional fibrosis assessment 1
  • Has effectively ruled out advanced fibrosis (F3-F4) with high confidence
  • Does not need transient elastography or patented serum tests at this time 1

Important Caveats

Age consideration: At 54 years, this patient is in the standard age range where FIB-4 performs optimally. However, be aware that:

  • FIB-4 accuracy may be affected in patients >65 years, where higher cutoffs (2.0 instead of 1.3) have been proposed for ruling out advanced fibrosis 1
  • This patient does not fall into this category

If FIB-4 were >1.3: Guidelines recommend using transient elastography (TE) with cutoff <8 kPa or patented tests (ELF™ <9.8, FibroMeter™ <0.45, or FibroTest® <0.48) as second-line testing to definitively rule out or rule in advanced fibrosis 1

Advantages of FIB-4 in Clinical Practice

  • Based on readily available laboratory values (age, AST, ALT, platelets)
  • Free online calculators available for bedside use
  • Good overall diagnostic accuracy (AUROC 0.80) for advanced fibrosis 1
  • High negative predictive value when <1.3 1, 2

Limitations to Consider

  • Modest positive predictive value (<70%) at higher cutoffs, risking false positives 1
  • Approximately one-third of patients fall in the indeterminate zone (1.3-3.25) 1
  • Performance may vary in specific populations (obesity, diabetes) where alternative cutoffs or complementary tests may be preferred 1

References

Related Questions

In a 35-year-old patient with a platelet count of 154 ×10⁹/L, is this value normal and does it warrant further evaluation for liver disease (e.g., calculation of the FIB‑4 score)?
What is the FIB‑4 score, how is it calculated, and what do its results indicate?
Does allopurinol inhibit thiopurine methyltransferase (TPMT)?
Is Twynsta (telmisartan/amlodipine) contraindicated in a patient with serum glutamate‑pyruvate transaminase (SGPT/alanine aminotransferase, ALT) 12 times the upper limit of normal?
In a 30‑year‑old Black male, 6′5″, 320 lb, with mixed connective‑tissue disease, G6PD deficiency, taking amlodipine and a GLP‑1 receptor agonist, who has mildly elevated creatinine, normal eGFR, normal liver enzymes, CK 371‑527 U/L, positive ANA with speckled pattern, markedly elevated anti‑RNP antibodies, and muscle weakness, what type of myositis is most likely (polymyositis, dermatomyositis, or necrotizing myopathy) and can he expect recovery with appropriate treatment while continuing physical therapy?
Is the combination of dapaglitazone and metformin contraindicated in a patient with serum glutamic‑oxaloacetic transaminase (SGOT/AST) greater than 12 times the upper limit of normal?
What is the most appropriate as-needed (PRN) medication for a patient who experiences panic attacks and has a known arrhythmia?
What is the most appropriate diagnosis and treatment for a 23-year-old female with acute severe psychosis (auditory and visual hallucinations, delusions, thought disorganization), depressive, anxiety, and manic symptoms, family history of schizophrenia and bipolar disorder, recent THC and alcohol use, prior suicide attempt and homicidal thoughts, currently on sertraline (Zoloft) and aripiprazole (Abilify), with medication noncompliance and housing instability?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.